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Branched-chain 2-oxoacid dehydrogenase complex is inactivated by phosphorylation of the a-subunit of 
the Er component of the complex. High-speed supernatant from rat liver mitochondria contains an 
activator protein which can restore activity to the phosphorylated complex without concomitant 
dephosphorylation [(1982) FEBS Lett. 147, 35-391. We report here several ines of evidence which indicate 
that activator is the dissociated non-phosphorylated form of the El component. 
Branched-chain 2-oxoacid dehydrogenase complex Phosphorylation activator 
(Rat liver mitochondria) 
El component 
1. INTRODUCTION 
The mitochondrial branched-chain 2-oxoacid 
dehydrogenase complex catalyses a rate-limiting 
step in the oxidation of the essential branched- 
chain amino acids [I]. The complex comprises a 
central core of a transacylase component (E2) 
around which are arranged the 2-oxoacid dehydro- 
genase (El) and dihydrolipoyl dehydrogenase (E3) 
components. Er consists of two non-identical 
subunits termed c~ and ,@ [2]. 
The activity of the complex is regulated by rever- 
sible phosphorylation. Inactivation results from 
phosphorylation of the a-subunit of the Ei compo- 
nent by a protein kinase which is intrinsic to the 
complex [3,4]. As with the pyruvate dehydroge- 
nase complex, which is regulated in an analogous 
manner [5], the phosphorylated form of the 
branched-chain 2-oxoacid dehydrogenase complex 
is essentially inactive under all assay conditions 
and no allosteric activators of the phosphorylated 
form are known. 
Recently however a protein ‘activator’ of phos- 
phorylated branched-chain 2-oxoacid dehydroge- 
nase complex has been reported in high-speed 
supernatant from rat liver and kidney mitochon- 
dria [6]. The factor, which is apparently absent 
from heart and muscle mitochondria, can restore 
full activity to the phosphorylated complex 
without dephosphorylation, re-activation being 
essentially instantaneous. Levels of the activator 
are sufficiently high as to lead to the suggestion 
that the activator may be of physiological signi- 
ficance and its absence from heart (and skeletal 
muscle) has been postulated as a partial explana- 
tion of the different regulation of the complex in 
liver and kidney as opposed to muscle [1,6]. 
Here, we report several pieces of evidence that 
the activator protein is in fact free Er component 
which has presumably dissociated from the com- 
plex during ultracentrifugation. A physiological 
role for the activator must therefore be seriously 
questioned. 
2. MATERIALS AND METHODS 
Branched-chain 2-oxoacid dehydrogenase com- 
plex from bovine kidney cortex was purified and 
assayed as in [7]. The specific activity of the final 
preparation was approx. 5 units/mg. Phosphor- 
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ylated complex was prepared as in 171. Unless 
otherwise indicated no attempt was made to 
remove the ATP-Mg from the final preparation. 
Ez-kinase sub-complex was obtained by resolution 
of the complex in high concentrations of sodium 
chloride (unpublished and [2]). The E2-kinase sub- 
complex was devoid of overall catalytic activity 
(even in the presence of added E3 component) and 
the ty- and &subunits of the Er component were 
completely absent, as indicated by polyacrylamide 
gel electrophoresis in the presence of SDS. 
Mitochondria from rat liver, kidney and heart 
were prepared essentially as in [8], using 0.25 M 
sucrose, 10 mM Tris-HCl (pH 7.3) as homogeni- 
sation buffer. They were then washed in 20 mM 
sodium phosphate, 0.1 mM EDTA, 15 mM P-mer- 
captoethanol (pN 7.3) and frozen, using liquid Nz, 
at a protein concentration of approx. 25 mglml. 
After freeze-thawing twice, high-speed superna- 
tant was obtained by centrifugation for 2 h at 
180000 x gaV at 4°C. This supernatant was devoid 
of pyruvate dehydrogenase and branched-chain 
2-oxoacid dehydrogenase activities. 
Activator in high-speed supernatant was assayed 
by addition to a reaction cuvette containing all the 
constituents necessary for assay of branched-chain 
2-oxoacid dehydrogenase plus either phosphor- 
ylated inactive branched-chain 2-oxoacid dehydro- 
genase complex (50/1g) or Ez-kinase sub-complex 
(50 f%)* 
3. RESULTS 
In agreement with [6], we have observed that 
high-speed supernatant from rat liver and kidney 
mit~hondria (but not heart) contains an activator 
protein which can restore full activity to phos- 
phorylated branched-chain 2-oxoacid dehydroge- 
nase complex (not shown). Al1 subsequent data 
refer to work with rat liver mitochondria but 
similar observations have been made using rat 
kidney. The activator can be precipitated by 
(Nfl[4)2S04 (45% saturation) but is relatively 
labile, its activity being destroyed by jncubatjon at 
30°C for 1 h or by storage overnight in dilute solu- 
tion at 4°C. However, after precipjtation with 
(NH4)2S04 it can be stored in (NH&SO4 at 
-20°C for several days without appreciable loss 
of activity. 
One possibility which seemed to merit investiga- 
tion was that activator protein is in fact dissociated 
Er component, which can recombine with the E2 
component of phosphorylated inactive complex to 
generate the overall catalytic activity of the com- 
plex. This was tested using Ez-kinase sub-complex 
which was devoid of EI. As can be seen in fig. 1, 
addition of a preparation of activator to excess E2 
(in the presence of excess E3) generates ignificant 
catalytic activity. This occurs essentially instan- 
taneously and the amount of activity achieved is 
proportional to the amount added of activator 
protein in the presence of excess EZ (fig. 1) or to the 
amount of E2 in the presence of excess activator 
protein (not shown). 
If the activator protein is in fact the EI compo- 
nent it should exhibit properties similar to those of 
EI. Transitjon-state analogues of thiamine 
pyrophosphate are potent inhibitors of the Er com- 
ponents of the 2-oxoacid dehydrogenase com- 
plexes [9,10]. One such analogue, thiamine 
thiothiazolone pyrophosphate (TTTPP), strongly 
inhibits bovine kidney branched-chain 2-oxoacid 
dehydrogenase complex, 50% inhibition being 
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Fig. I. Effect of activator protein on the branched-chain 
2-oxoacid dehydrogenase activity of the purified E2 
component of the complex. Taken from trace from a 
Cecil 272 linear readout spectrophotometer linked to a 
chart recorder. The cuvette contained (in 1 ml) the 
appropriate substrates and co-factors (including E3) for 
assay of branch~-chain 2-oxoacid ehydrogenase [7]. 
E2 (Spg) and activator, (A) 15 pg protein; (B) 6opg 
protein, purified by precipitation using (NH&X&, were 
added as indicated. The activator preparation had no 
detectable branched-chain 2-oxoacid dehydrogenase 
activity (not shown). 
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Fig.2. Effect of thiamine thiothiazofone pyrophosphate 
(TTTPP) on activity of branched-chain 2-oxoacid 
dehydrogenase complex and of activator protein. 
Samples (purified complex or mitochondrial high-speed 
supernatant) were me-incubated for 5 min at 20°C with 
the indicated concentration of TTTPP and then aliquots 
(IO pi) were assayed for branched-chain 2-oxoacid 
dehydrogenase activity. Activator in the high-speed 
supernatant was assayed in the presence of excess EZ 
(50 pg) and Es. Branched-chain 2-oxoacid dehydroge- 
nase complex (o), activator protein (0). Addition of 
10-s M TTTPP directly to a reaction cuvette had no 
significant effect on the activity of a sample of complex. 
observed at approx. low7 M (fig.2). The activator 
protein is also inhibited by TTTPP, inhibition be- 
ing observed over the same range of concentrations 
of TTTPP (fig.2). 
A key property of Er is that, at least when bound 
to the complex, it can be phosphoryIated and inac- 
tivated by a specific protein kinase intrinsic to the 
complex [3,4,11], We therefore investigated the ef- 
fect of the kinase on the properties of the ac- 
tivator, using phosphorylated branched-chain 
2-oxoacid dehydrogenase complex as a source of 
kinase. When phosphorylated complex is in- 
cubated with high-speed supernatant in the 
presence of ATP-Mg, the activity of the activator 
is lost. The loss of activator is a time-dependent, 
ATP-dependent process, indicative of the involve- 
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Fig.3. Inactivation of activator protein under conditions 
favouring phosphorylation. Mitochondrial high-speed 
supernatant (4.5 mg protein, containing 0.08 units of 
activity when assayed in the presence of phosphorylated 
complex) was incubated at 20°C with excess 
phosphorylated (inactive) branched-chain 2-oxoacid 
dehydrogenase complex (6OOyg, added as a source of 
kinase and to allow quantitation of activator) in a finaf 
volume of 300,zl sodium phosphate (30 mM, pH 7.3), 
containing EDTA (0.1 mM), P-mercaptoethanol 
(1.5 mM), NaF (50 mM), oligomycin B (lOpg/ml), 
MgC12 (10 mM) and ATP (OS mM). Ahquots (40111) 
were removed at the indicated times and assayed for 
branched-chain 2-oxoacid dehydrogenase activity (*). 
In the control incubation (o), ATP was omitted and the 
phospho~lated complex was pre-treated with glucose 
and hexokinase f7] to scavenge any residual ATP. 
ment of a phosphorylation mechanism (fig.3). 
When Et-kinase complex (devoid of El) is in- 
cubated with high-speed supernatant in the 
presence of [q+32P]ATP-Mg, apolypeptide of Mr = 
46000 becomes phosphorylated (fig.4). This 
subunit size corresponds to that of the a-subunit of 
the Er component {2]. 
4. DISCUSSION 
Here we confirm the basic observations in [6] 
that high-speed supernatant from rat liver (and 
kidney but not heart) mito~hondria contains a pro- 
tein activator which can activate the phosphor- 
ylated form of the branched-chain 2-oxoacid 
dehydrogenase complex. However, we present 
several pieces of evidence which indicate that the 
activator is in fact free dissociated EI component 
of the complex. The strongest evidence in support 
of this is the observation that activator from high- 
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Fig.4. Phosphorylation of mitochondrial high-speed 
super~atant by Ep-kinase sub-complex. High-speed 
supernatant (45Opg protein) was incubated at 20°C for 
30 min with [y-32P]ATP (0.5 mM, 200 cpm/pmol), 
MgClz (10 mM), NaF (50 mM), oligomycin B 
(10 pg/ml) in a total volume of 30 pl in the absence (A) 
and presence (B) of E2-kinase (30 pg). An aliquot (10 ~1) 
was then analysed by SDS-polyacrylamide gel 
electrophoresis and autoradiography as in 171. No 
phosphorylation was detected using Ez-kinase in the 
absence of high-speed supernatant (not shown). 
speed supernatant can confer on Ez-Es sub- 
complex the ability to oxidise branched-chain 
2-oxoacids (fig. 1). This demonstrates that high- 
speed supernatant contains active EI component 
which can interact with EZ and generate overall 
catalytic activity (in the presence of Es). It seems 
likely therefore that Er can interact with the E2 
core of phosphorylated inactive complex to restore 
overall catalytic activity. We have recently been 
able to demonstrate that homogeneous prepara- 
tions of Er, obtained by resoiution of the purified 
complex, can restore activity to the phosphory- 
Iated complex or EZ component (unpublished). It is 
not yet clear whether Er acts by displacing phos- 
phorylated Er from the complex or by binding to 
unoccupied sites on the E2 core. Detailed studies 
using purified complex and components will be 
necessary to resolve this question. Further evidence 
that activator protein is Er includes the observation 
that activator ‘activity’ is lost following pre-treat- 
ment with a transition state analogue of thiamine 
pyrophosphate, an essential co-factor for Er 
(fig.2). Furthermore, activator ‘activity’ is 
destroyed in a time-dependent manner by incuba- 
tion with ATP-Mg and a source of the kinase con- 
sidered to be specific for Er of the branched-chain 
2-oxoacid dehydrogenase complex (fig.3). Loss of 
activity is apparently associated with phosphoryla- 
tion of a polypeptide of M, = 46000, although we 
are not yet able to exclude totally the possibility 
that other minor polypeptides in the high-speed 
supernatant become phosphorylated and are 
associated with loss of activator function. 
However, this seems unlikely, 
Failure to detect the activator in supernatant 
from heart mitochondria may be explained by the 
observation that, in heart, the complex (and 
therefore free Er) is predominantly in the phos- 
phorylated, inactive form. 
We do not yet know whether Er found in 
mitochondria1 high-speed supernatant has failen 
from the complex during preparation of the extract 
and subsequent ultracentrifugation, as is the case 
with the E3 component [2], or else whether free 
dissociated El exists within the mitochondria. In 
either case it is difficult to envisage a regulatory 
role for this free El activity. 
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